172 related articles for article (PubMed ID: 31177376)
21. Matched-pair analysis comparing the outcomes of T cell/histiocyte-rich large B cell lymphoma and diffuse large B cell lymphoma in patients treated with rituximab-CHOP.
Kim YS; Ji JH; Ko YH; Kim SJ; Kim WS
Acta Haematol; 2014; 131(3):156-61. PubMed ID: 24192382
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, in the Oral Cavity.
Costa SFDS; Silva AMB; Amaral-Silva GK; Pontes HAR; Pontes FSC; Fonseca FP; Almeida OP
J Craniofac Surg; 2019; 30(3):e259-e262. PubMed ID: 31048622
[TBL] [Abstract][Full Text] [Related]
23. Neurolymphomatosis: a case study of diffuse large B-cell lymphoma.
Casselberry JN; Kritz AD
Clin J Oncol Nurs; 2012 Dec; 16(6):636-7. PubMed ID: 23178357
[TBL] [Abstract][Full Text] [Related]
24. [Chinese guidelines for diagnosis and treatment of diffuse large B cell lymphoma(2013)].
;
Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):816-9. PubMed ID: 24103886
[No Abstract] [Full Text] [Related]
25. Composite lymphoma with diffuse large B-cell lymphoma and classical Hodgkin lymphoma components: A case report and review of the literature.
Goyal G; Nguyen AH; Kendric K; Caponetti GC
Pathol Res Pract; 2016 Dec; 212(12):1179-1190. PubMed ID: 27887763
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological analysis of primary splenic diffuse large B-cell lymphoma.
Shimono J; Miyoshi H; Kiyasu J; Sato K; Kamimura T; Eto T; Miyagishima T; Nagafuji K; Teshima T; Ohshima K
Br J Haematol; 2017 Sep; 178(5):719-727. PubMed ID: 28493517
[TBL] [Abstract][Full Text] [Related]
27. JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML).
Maeda Y
Int J Hematol; 2024 Apr; 119(4):347-373. PubMed ID: 38483689
[No Abstract] [Full Text] [Related]
28. Cutaneous CD4+ CD56+ hematologic malignancies.
Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
[TBL] [Abstract][Full Text] [Related]
29. [Abnormal Expression and Clinical Significance of B Lymphocyte Stimulating Factor in B Cell-derived Malignant Hematologic Diseases].
Han XL; Zhang XY; Li JD; Wang WL; Yang C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):138-141. PubMed ID: 28245390
[TBL] [Abstract][Full Text] [Related]
30. Management of diffuse large B-cell lymphoma (DLBCL).
Kubuschok B; Held G; Pfreundschuh M
Cancer Treat Res; 2015; 165():271-88. PubMed ID: 25655614
[TBL] [Abstract][Full Text] [Related]
31. [Japanese Society of Hematology, clinical practice guideline: diffuse large B cell lymphoma].
Ohmachi K
Rinsho Ketsueki; 2013 Oct; 54(10):1756-63. PubMed ID: 24064826
[No Abstract] [Full Text] [Related]
32. Guidelines for NHL: updates to the management of diffuse large B-cell lymphoma and new guidelines for primary cutaneous CD30+ T-cell lymphoproliferative disorders and T-cell large granular lymphocytic leukemia.
Zelenetz AD
J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):797-800. PubMed ID: 24853220
[TBL] [Abstract][Full Text] [Related]
33. Clinical approach to diffuse large B cell lymphoma.
Caimi PF; Hill BT; Hsi ED; Smith MR
Blood Rev; 2016 Nov; 30(6):477-491. PubMed ID: 27596109
[TBL] [Abstract][Full Text] [Related]
34. The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies.
Twa DDW; Mottok A; Savage KJ; Steidl C
Blood Rev; 2018 May; 32(3):249-255. PubMed ID: 29289361
[TBL] [Abstract][Full Text] [Related]
35. [Hematology 2009].
Dreyling M; Spiekermann K; Hiddemann W
Dtsch Med Wochenschr; 2009 Jun; 134(25-26):1367-9. PubMed ID: 19517333
[No Abstract] [Full Text] [Related]
36. Primary composite lymphoma of the larynx, composed of diffuse large B-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified, presenting as left subglottic tracheal fistula, esophageal diverticulum, and neck abscess.
Cui W; Fan F; Zhang D; Garnett D; Tilzer L
Ann Clin Lab Sci; 2012; 42(1):73-80. PubMed ID: 22371913
[TBL] [Abstract][Full Text] [Related]
37. Performance of a Commercially Available MAL Antibody in the Diagnosis of Primary Mediastinal Large B-Cell Lymphoma.
Gentry M; Bodo J; Durkin L; Hsi ED
Am J Surg Pathol; 2017 Feb; 41(2):189-194. PubMed ID: 27879516
[TBL] [Abstract][Full Text] [Related]
38. Diffuse large B-cell lymphoma: current strategies and future directions.
Cultrera JL; Dalia SM
Cancer Control; 2012 Jul; 19(3):204-13. PubMed ID: 22710896
[TBL] [Abstract][Full Text] [Related]
39. Secondary CD5+ diffuse large B-cell lymphoma not associated with transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (Richter syndrome).
Maeshima AM; Taniguchi H; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
Am J Clin Pathol; 2009 Mar; 131(3):339-46. PubMed ID: 19228640
[TBL] [Abstract][Full Text] [Related]
40. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.
Bellan C; Stefano L; Giulia de F; Rogena EA; Lorenzo L
Hematol Oncol; 2010 Jun; 28(2):53-6. PubMed ID: 19844983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
